College of Psychiatric and Neurologic Pharmacists

Live: # 0284-9999-12-002-L01-P (Application)
Online: # 0284-9999-12-002-H01-P (Application)

Learning Objectives:

1. Evaluate the efficacy of antidepressant therapy in mild, moderate and severe major depressive disorder.
2. Differentiate the role of monotherapy, comedication or augmentation strategies in the treatment of depressive disorders.
3. Appraise response to pharmacotherapy and adequacy of treatment in patients with depressive disorders.
4. Contrast current controversies in the use of antidepressants in depressive disorders (e.g., use in acute bipolar depression, suicidality, efficacy).

Professor of Psychiatry, Director Mood Disorders Program, Tufts Medical Center, Boston, MA

Live: # 0284-9999-12-003-L04-P (Application)
Online: # 0284-9999-12-003-H04-P (Application)

Learning Objectives:

1. Differentiate the various contemporary bariatric surgical procedures and their implications on absorption kinetics.
2. Assess common post-surgical neurological complications associated with nutritional deficiencies.
3. Develop a plan for vitamin and nutritional management.
4. Analyze specific medications and dosage forms pertinent to psychotropic medications.

Associate Professor of Pharmacy & Interdisciplinary Faculty in Nutritional Sciences, University of Washington, Seattle, WA

Live: # 0284-9999-12-004-L01-P (Application)
Online: # 0284-9999-12-004-H01-P (Application)

Learning Objectives:

1. Explain the normal function of nicotine related to thought processes.
2. Characterize the pathophysiological changes in the nicotine system responsible for manifestations of schizophrenia.
3. Explain the effects of smoking and smoking cessation on symptoms of schizophrenia.
4. Recommend a plan of action for a patient with schizophrenia who smokes tobacco.

Associate Professor of Psychiatry, Director & Chief, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD

Live: # 0284-9999-12-009-L04-P (Application)
Online: # 0284-9999-12-009-H04-P (Application)

Learning Objectives:

1. Apply appropriate risk assessment strategies (i.e., Risk Evaluation and Mitigation Strategies [REMS], Universal Precautions) for the abuse, misuse, and diversion of opioid therapies used in the management of chronic pain.
2. Select screening instruments to identify patients at risk for opioid dependence and/or abuse.
3. Evaluate abuse-deterrent technologies associated with opioid therapy.
4. Evaluate evidence-based literature for patient-related factors associated with risk of relapse if opioid medications are used to treat pain in patients with a history of addiction.
5. Formulate a response to challenges encountered in the management of chronic pain in patients at risk for, or with a history of, addiction.
6. Contrast options for pharmacotherapy (e.g., nonsteroidal anti-inflammatory drugs [NSAIDs], opioid therapies, adjunctive agents) for chronic pain in patients at risk for, or with a history of, addiction.

Clinical Associate Professor, University of Georgia College of Pharmacy, Athens, GA

President, C-Health, P.C., Lebanon, VA